XTORO 3 mg/mL
finafloxacin · SUSPENSION · Fonseca Biosciences, LLC
No Recall History
Plain English
XTORO is a suspension containing finafloxacin at 3 mg/mL, taken auricular (otic). Manufactured by Fonseca Biosciences, LLC.
Key Facts
- Brand Name
- XTORO
- Generic Name
- finafloxacin
- NDC Code (Product)
83709-001- Manufacturer
- Fonseca Biosciences, LLC
- Strength
- 3 mg/mL
- Dosage Form
- SUSPENSION
- Route
- AURICULAR (OTIC)
- Marketing Status
- Application #
- NDA206307
- Drug Class
- Quinolone Antimicrobial [EPC]
- Marketing Start
- 05/01/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is XTORO used for?
XTORO contains finafloxacin. It is a suspension taken auricular (otic). Consult your doctor for specific uses.
Is XTORO a controlled substance?
XTORO is not classified as a controlled substance by the DEA.
What is the generic name for XTORO?
The generic name for XTORO is finafloxacin. There are no other listed brand versions of finafloxacin.
What is the NDC code for XTORO 3 mg/mL?
The NDC (National Drug Code) for XTORO 3 mg/mL is 83709-001, listed by Fonseca Biosciences, LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)